These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32723531)

  • 1. Characteristics of Patients with Late-Stage Parkinsonism Who are Nursing Home Residents Compared with those Living at Home.
    Hosking A; Hommel AALJ; Lorenzl S; Coelho M; Ferreira JJ; Meissner WG; Odin P; Bloem BR; Dodel R; Schrag A;
    J Am Med Dir Assoc; 2021 Feb; 22(2):440-445.e2. PubMed ID: 32723531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication use in people with late stage Parkinson's disease and parkinsonism living at home and in institutional care in north-east England: A balance of symptoms and side-effects?
    Hand A; Gray WK; Oates LL; Woolford M; Todd A; Bale E; Jones C; Wood BH; Walker RW
    Parkinsonism Relat Disord; 2016 Nov; 32():120-123. PubMed ID: 27622968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor profile and drug treatment of nursing home residents with Parkinson's disease.
    Weerkamp NJ; Zuidema SU; Tissingh G; Poels PJ; Munneke M; Koopmans RT; Bloem BR
    J Am Geriatr Soc; 2012 Dec; 60(12):2277-82. PubMed ID: 23231550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential progression of motor impairment in levodopa-treated Parkinson's disease.
    Goetz CG; Stebbins GT; Blasucci LM
    Mov Disord; 2000 May; 15(3):479-84. PubMed ID: 10830412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study.
    Aarsland D; Larsen JP; Tandberg E; Laake K
    J Am Geriatr Soc; 2000 Aug; 48(8):938-42. PubMed ID: 10968298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
    Bracco F; Battaglia A; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL;
    CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa Effect and Motor Function in Late Stage Parkinson's Disease.
    Rosqvist K; Horne M; Hagell P; Iwarsson S; Nilsson MH; Odin P
    J Parkinsons Dis; 2018; 8(1):59-70. PubMed ID: 29480220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life.
    Weerkamp NJ; Tissingh G; Poels PJ; Zuidema SU; Munneke M; Koopmans RT; Bloem BR
    J Am Geriatr Soc; 2013 Oct; 61(10):1714-21. PubMed ID: 24117286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ropinirole: a review of its use in the management of Parkinson's disease.
    Matheson AJ; Spencer CM
    Drugs; 2000 Jul; 60(1):115-37. PubMed ID: 10929932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial.
    Lee JY; Jeon B; Koh SB; Yoon WT; Lee HW; Kwon OD; Kim JW; Kim JM; Ma HI; Kim HT; Baik JS; Cho J;
    J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):30-37. PubMed ID: 30361296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of withdrawal of dopaminergic medication in nursing home patients with advanced parkinsonism.
    Tse W; Frisina PG; Hälbig TD; Gracies JM; Liang L; Tarshish C; Lesser G; Neufeld R; Koller WC; Libow LS
    J Am Med Dir Assoc; 2008 Nov; 9(9):670-5. PubMed ID: 18992700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study.
    Biundo R; Weis L; Abbruzzese G; Calandra-Buonaura G; Cortelli P; Jori MC; Lopiano L; Marconi R; Matinella A; Morgante F; Nicoletti A; Tamburini T; Tinazzi M; Zappia M; Vorovenci RJ; Antonini A
    Mov Disord; 2017 Nov; 32(11):1557-1565. PubMed ID: 28960475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
    Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C
    Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
    Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caregiver Burden in Late-Stage Parkinsonism and Its Associations.
    Kalampokini S; Hommel ALAJ; Lorenzl S; Ferreira JJ; Meissner WG; Odin P; Bloem BR; Dodel R; Schrag AE
    J Geriatr Psychiatry Neurol; 2022 Jan; 35(1):110-120. PubMed ID: 33094677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinsonism in a nursing home: underrecognition.
    Friedman JH; Fernandez HH; Trieschmann MM
    J Geriatr Psychiatry Neurol; 2004 Mar; 17(1):39-41. PubMed ID: 15018697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Status of Elderly Nursing Home Residents With Parkinson's Disease.
    Chekani F; Bali V; Aparasu RR
    J Parkinsons Dis; 2016 Jun; 6(3):617-24. PubMed ID: 27258696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing Treatment in Undertreated Late-Stage Parkinsonism: A Pragmatic Randomized Trial.
    Hommel ALAJ; Meinders MJ; Weerkamp NJ; Richinger C; Schmotz C; Lorenzl S; Dodel R; Coelho M; Ferreira JJ; Tison F; Boraud T; Meissner WG; Rosqvist K; Timpka J; Odin P; Wittenberg M; Bloem BR; Koopmans RT; Schragand A;
    J Parkinsons Dis; 2020; 10(3):1171-1184. PubMed ID: 32568111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
    Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.